DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Modeling Impaired Judgement in Cocaine Abusers - 6

Information source: National Institute on Drug Abuse (NIDA)
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Cocaine-Related Disorders; Substance-Related Disorders

Intervention: Amantadine (Behavioral)

Phase: Phase 4

Status: Completed

Sponsored by: National Institute on Drug Abuse (NIDA)

Official(s) and/or principal investigator(s):
John Rotrosen, M.D., Principal Investigator, Affiliation: New York MDRU

Summary

The purpose of this study is for the modeling of impaired judgement in cocaine abusers.

Clinical Details

Official title: Modeling Impaired Judgement in Cocaine Abusers

Study design: Masking: Open Label, Primary Purpose: Prevention

Detailed description: The objective of this study is to investigate recognition memory and appreciation of changing contingencies in relation to a response judgement.

Eligibility

Minimum age: 18 Years. Maximum age: 60 Years. Gender(s): Both.

Criteria:

Inclusion Criteria: (3 groups)Normal, healthy controls. Recent cocaine experience. Over 6 months since the last cocaine experience. Exclusion Criteria: Psychosis or mood disorder. History of seizure, head trauma

Locations and Contacts

New York MDRU, New York, New York 10010, United States
Additional Information

Related publications:

NIDA Research Monograph Series 179, 1998 CPDD 98, 99.

Starting date: March 1997
Last updated: November 3, 2005

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017